Company Filing History:
Years Active: 2010-2015
Title: The Innovative Contributions of Inventor Anne Stürzebecher
Introduction
Anne Stürzebecher, a prominent inventor based in Weimar, Germany, has made significant strides in the field of medicinal chemistry. With two patents to her name, she has been instrumental in developing new therapeutic agents aimed at addressing critical health issues. Her work reflects a commitment to innovation and a pursuit of solutions for cardiovascular diseases.
Latest Patents
Stürzebecher’s latest patents include groundbreaking inventions in the realm of coagulation factors and amino acid derivatives.
1. **Base-substituted benzylamine analogs for use as coagulation factor Xa inhibitors** - This invention presents novel base-substituted benzylamine analogs of general formula (I), designed to function as inhibitors of coagulation factor Xa. The innovations detailed in this patent promise therapeutic applications in the management of cardiovascular diseases and thromboembolic events.
2. **N-sulphonylated amino acid derivatives, method for the production and use thereof** - This patent relates to N-sulfonylated amino acid derivatives, featuring an aryl radical linked via the sulfonyl group to the amino acid. Furthermore, these compounds are designed to incorporate a radical containing at least one imino group and another basic group. The patent outlines the processes for their preparation and highlights their potential as inhibitors of matriptase.
Career Highlights
Anne Stürzebecher is currently affiliated with The Medicines Company (Leipzig) GmbH, where she applies her expertise in developing innovative pharmaceuticals. Her contributions have not only advanced the field but have also paved the way for potential treatments that can greatly benefit patients worldwide.
Collaborations
Throughout her career, Stürzebecher has collaborated with esteemed colleagues, including Jörg Stürzebecher and Torsten Steinmetzer. These partnerships have enriched her research endeavors and have led to significant advancements in her projects, showcasing the power of teamwork in the pursuit of innovation.
Conclusion
Inventor Anne Stürzebecher exemplifies the spirit of innovation within the scientific community. Her patents not only signify her dedication to improving health outcomes but also reflect her role as a key player in medicinal research. As new therapies emerge from her work, the impact of her inventions is poised to be felt in healthcare sectors around the globe.